Ghali, Michael George Zaki <br/><br/>
Therapeutically Targeting Platelet-Derived Growth Factor-Mediated Signaling Underlying the Pathogenesis of Subarachnoid Hemorrhage-Related Vasospasm.  [electronic resource] 

 -  Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association  Sep 2018 
 - 2289-2295 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1532-8511 
<br/><br/><label>Standard No.: </label>10.1016/j.jstrokecerebrovasdis.2018.02.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cerebral Arteries--drug effects<br/>Drug Design<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects<br/>Molecular Targeted Therapy--adverse effects<br/>Proto-Oncogene Proteins c-sis--antagonists & inhibitors<br/>Receptor, Platelet-Derived Growth Factor beta--antagonists & inhibitors<br/>Serine Proteinase Inhibitors--adverse effects<br/>Signal Transduction--drug effects<br/>Subarachnoid Hemorrhage--complications<br/>Vasospasm, Intracranial--drug therapy